joimax® Announces New Distribution Partners in Brazil and Japan and Expands International Market Presence as Part of Growth Strategy

Karlsruhe, GER– February 8, 2019 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, is pleased to announce its expanded international market presence with new distribution partners in Brazil and Japan.
In Brazil, joimax® is partnering with the privately-owned CT Group, which offers more than 20 years experience in the medical technology market. CT Group delivers a unique strategy and approach in the Brazilian market, focusing on the spine segment. The group is composed of 5 affiliated companies that provide innovative and high standard medical devices and equipment throughout the country.

“We are very happy to represent joimax® and its complete endoscopic product portfolio in Brazil,” states Volnei Luiz Ortigara, Chairman of the Brazilian CT Group. “Together, we will ensure an outstanding market presence”.

Currently, there are 50 potential providers in Brazil who have been trained on the joimax® methods and will be able to start offering joimax® endoscopic procedures this spring. In Japan, joimax® is partnering with United Biomech Japan, Inc., who will oversee distribution of the complete joimax® product line countrywide. The official market launch will take place at the 48th Annual Meeting of the Japanese Society for Spine Surgery and Related Research (JSSR), April 18 – 20, 2019 in Yokohama, Japan. The agreement coincides with the Japan-EU Free Trade Agreement (JEFTA) which came into effect February 1, 2019.
“This is the first time joimax® will be involved with the Japanese market,” states Wolfgang Ries, Founder and CEO of the joimax® Group. “We are excited to extend our global reach and offer superior medical products and training internationally.”

The presence in these two major markets is part of the overall growth strategy for joimax® further positioning the company as a leader in the spine industry.

 

Groupphoto PR 2019 Japan Brazil

joimax® Expands Distribution in Italy – Announces New Partnership with Uber Ros S.p.A

KARLSRUHE, Germany – (BUSINESS WIRE) – German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, and distributor Uber Ros S.p.A are excited to announce their new partnership for the Italian market, effective immediately.

Under this strategic alliance, Uber Ros will be a full sales and service provider of joimax® products to surgeons and medical practitioners throughout Italy. The partnership allows both companies to expand the renowned joimax® brand via first-rate networks and distribution channels to the Italian health community, ensuring that patients have access to the latest spinal endoscopic technologies.

“We’re looking forward to working with Uber Ros, a strong and well-established partner in Italy,” says joimax® Founder and CEO Wolfgang Ries.<
“Together, we will continue to provide best-in-class service and grow our presence in the Italian spine community while creating a solid business growth strategy,” states Uber Ros President and COO Giorgio Rosati.

In addition, the acclaimed joimax® training and education program for spine physicians, managed under ESPINEA®, the Endoscopic Spine Academy powered by joimax®, will be introduced in Italy. “Uber Ros and joimax® will align all education activities and set-up special workshop programs that offer certified courses to Italian physicians,” says ESPINEA® Chairman Wolfgang Ries.

About Uber Ros S.p.A

Uber Ros S.p.A was founded in Rome in 1986 by Dr. Umberto Rosati and his son Giorgio. It is a Medical Devices Distribution Company active in all Italian territories. Uber Ros promotes and sells high-tech medical devices, mainly specialized in Orthopedics, Trauma Surgery, Neurosurgery, Spine, Maxillo-Facial, Head and Neck surgery (ENT-OTO), Wound Care and Vascular surgery. Uber Ros has a sales organization spread throughout Italy, providing customer service 24 hours on any day of the year. The Company collaborates with the world leading Research Centers, and is involved in the most advanced studies on bioengineering, promoting and supporting scientific research in high-tech emerging fields.